Movement Disorders (revue) - Exploration (Accueil)

Index « Titre (en) » - entrée « efficacy »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
efficacious < efficacy < efficiency  Facettes :

List of bibliographic references indexed by efficacy

Number of relevant bibliographic references: 61.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000531 (2014) Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis]Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
000929 (2013) Stewart A. Factor [États-Unis] ; Kenneth Wolski ; Daniel M. Togasaki ; Susan Huyck ; Marc Cantillon ; T W Ho ; Robert A. Hauser ; Emmanuelle PourcherLong-term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease.
000C25 (2012) Robert Chinnapongse [États-Unis] ; Kristen Gullo ; Paul Nemeth ; Yuxin Zhang ; Lynn GriggsSafety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: a prospective double-blind trial.
000D18 (2012) Tetsutaro Ozawa ; Kanako Sekiya ; Yumi Sekine ; Takayoshi Shimohata ; Masahiko Tomita ; Hideaki Nakayama ; Naotaka Aizawa ; Ryoko Takeuchi ; Takayoshi Tokutake ; Shinichi Katada ; Masatoyo NishizawaMaintaining glottic opening in multiple system atrophy: efficacy of serotonergic therapy.
000D59 (2012) Ludvic Zrinzo ; Thomas Foltynie ; Patricia Limousin ; Marwan HarizImage-verified deep brain stimulation reduces risk and cost with no apparent impact on efficacy.
000E11 (2012) Bruno Dubois [France] ; Eduardo Tolosa ; Regina Katzenschlager ; Murat Emre ; Andrew J. Lees ; Günther Schumann ; Emmanuelle Pourcher ; Julian Gray ; Gail Thomas ; Jina Swartz ; Timothy Hsu ; Margaret L. MolineDonepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study.
000F91 (2012) Robert Chinnapongse [États-Unis] ; Kristen Gullo [États-Unis] ; Paul Nemeth [États-Unis] ; YUXIN ZHANG [États-Unis] ; Lynn Griggs [États-Unis]Safety and Efficacy of Botulinum Toxin Type B for Treatment of Sialorrhea in Parkinson's Disease: A Prospective Double-Blind Trial
001065 (2012) Tetsutaro Ozawa [Japon] ; Kanako Sekiya [Japon] ; Yumi Sekine [Japon] ; Takayoshi Shimohata [Japon] ; Masahiko Tomita [Japon] ; Hideaki Nakayama [Japon] ; Naotaka Aizawa [Japon] ; Ryoko Takeuchi [Japon] ; Takayoshi Tokurake [Japon] ; Shinichi Katada [Japon] ; Masatoyo Nishizawa [Japon]Maintaining Glottic Opening in Multiple System Atrophy: Efficacy of Serotonergic Therapy
001143 (2012) Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Gunther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis]Donepezil in Parkinson's Disease Dementia: A Randomized, Double-Blind Efficacy and Safety Study
001565 (2011) Rebecca Stowe [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Kelly Handley [Royaume-Uni] ; Alexandra Furmston [Royaume-Uni] ; Katherine Deane [Royaume-Uni] ; J. J. Van Hilten [Pays-Bas] ; Keith Wheatley [Royaume-Uni] ; Richard Gray [Royaume-Uni]Meta‐analysis of the comparative efficacy and safety of adjuvant treatment to levodopa in later Parkinson's disease
001582 (2011) Mathias Toft [Norvège] ; B Rd Lilleeng [Norvège] ; Jon Ramm-Pettersen [Norvège] ; Inger Marie Skogseid [Norvège] ; Vidar Gundersen [Norvège] ; Remo Gerdts [Norvège] ; Lena Pedersen [Norvège] ; Mona Skjelland [Norvège] ; Geir Ketil R Ste [Norvège] ; Espen Dietrichs [Norvège]Long‐term efficacy and mortality in Parkinson's disease patients treated with subthalamic stimulation
001682 (2011) Joseph Jankovic [États-Unis] ; Cynthia Comella [États-Unis] ; Angelika Hanschmann [Allemagne] ; Susanne Grafe [Allemagne]Efficacy and safety of incobotulinumtoxinA (NT 201, Xeomin) in the treatment of blepharospasm—A randomized trial
001785 (2011) Anna Prats París [Espagne] ; Heidi Guerra Saleta [Espagne] ; Maria De La Cruz Crespo Maraver [Espagne] ; Emmanuel Silvestre [États-Unis] ; Maite Garolera Freixa [Espagne] ; Cristina Petit Torrellas [Espagne] ; Silvia Alonso Pont [Espagne] ; Marc Fabra Nadal [Espagne] ; Sheila Alcaine Garcia [Espagne] ; Maria Victoria Perea Bartolomé [Espagne] ; Valentina Ladera Fernández [Espagne] ; Àngels Rusi Ol Bayés [Espagne]Blind randomized controlled study of the efficacy of cognitive training in Parkinson's disease
001896 (2011) Anna Prats Paris [Espagne] ; Heidi Guerra Saleta [Espagne] ; Maria De La Cruz Crespo Maraver [Espagne] ; Emmanuel Silvestre [États-Unis] ; Maite Garolera Freixa [Espagne] ; Cristina Petit Torrellas [Espagne] ; Silvia Alonso Pont [Espagne] ; Marc Fabra Nadal [Espagne] ; Sheila Alcaine Garcia [Espagne] ; Maria Victoria Perea Bartolome [Espagne] ; Valentina Ladera Fernandez [Espagne] ; Angels Bayes Rusinol [Espagne]Blind Randomized Controlled Study of the Efficacy of Cognitive Training in Parkinson's Disease
001A21 (2010) Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
001C02 (2010) Elisabeth Wolf [Autriche] ; Klaus Seppi [Autriche] ; Regina Katzenschlager [Autriche] ; Guenter Hochschorner [Autriche] ; Gerhard Ransmayr [Autriche] ; Petra Schwingenschuh [Autriche] ; Erwin Ott [Autriche] ; Iris Kloiber [Autriche] ; Dietrich Haubenberger [Autriche] ; Eduard Auff [Autriche] ; Werner Poewe [Autriche]Long‐term antidyskinetic efficacy of amantadine in Parkinson's disease
001D19 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
001D94 (2010) Yoshikuni Mizuno [Japon] ; Kazuko Hasegawa [Japon] ; Tomoyoshi Kondo [Japon] ; Sadako Kuno [Japon] ; Mitsutoshi Yamamoto [Japon]Clinical efficacy of istradefylline (KW‐6002) in Parkinson's disease: A randomized, controlled study
001E59 (2010) Michele Terzaghi [Italie] ; Valter Rustioni [Italie] ; Raffaele Manni [Italie] ; Claudio Pacchetti [Italie] ; Roberta Zangaglia [Italie] ; Maria Ossola [Italie]Agrypnia with nocturnal confusional behaviors in dementia with Lewy bodies: Immediate efficacy of rivastigmine
002139 (2009) David Devos [France]Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
002767 (2008) David Maltête [France] ; Stéphane Derrey [France] ; Nathalie Chastan [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Pierre Fréger [France] ; Bruno Mihout [France] ; Jean François Menard [France] ; Didier Hannequin [France]Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "efficacy" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "efficacy" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    efficacy
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024